THY1 and neoplasm: Additionally, multiplex immunohistochemistry (mIHC), performed in situ on Bone Met tumor as the single-cell expression, confirmed the co-localization of CD90 and RANKL (Fig. 6F and Additional file 2: Fig. S7E).